NOT KNOWN DETAILS ABOUT BMS-986141

Investigators also look to assess linvoseltamab in relapsed/refractory numerous myeloma as Component of the section three LINKER-MM3 demo."NCI is devoted to sharing info in accordance with NIH coverage. For more details on how scientific trial facts is shared, accessibility the website link towards the NIH info sharing policy web site."Supplementar